Azenta Inc at Jefferies Healthcare Conference Transcript
All right. We'll go ahead and get started. Good afternoon, everyone, and welcome to the Jefferies 2022 Global Healthcare Conference. It is great to see everyone back in person today. I'm Brandon Couillard. I cover the life science tools and diagnostics market and very happy to have the former Brooks team, now Azenta with us back at the conference this year. Here to give us an update on the story, Steve Schwartz, President and CEO; and Lindon Robertson, CFO, Lindon?
Thanks, Brandon, and thank you for everybody's attention. The Jefferies conference has just really been good to us over the years. It's one of the more robust with investors and has been a terrific conference for us. So thank you for inviting and including us.
I'll go fast. Obviously, we'll observe the safe harbor statements here. We'll be making some forward-looking statements and not obligated to update those any given time, but we'll do our best to give you a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |